Title of article :
Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia
Author/Authors :
Dujovne، نويسنده , , Carlos A and Ettinger، نويسنده , , Mark P and McNeer، نويسنده , , J.Frederick and Lipka، نويسنده , , Leslie J and LeBeaut، نويسنده , , Alexandre P and Suresh، نويسنده , , Ramachandran and Yang، نويسنده , , B.o and Veltri، نويسنده , , Enrico P، نويسنده ,
Abstract :
The efficacy and safety of ezetimibe, a new cholesterol absorption inhibitor, was evaluated in this randomized, double-blind, placebo-controlled trial of 892 patients with primary hypercholesterolemia. After ≥2 weeks on the National Cholesterol Education
